273 related articles for article (PubMed ID: 18191509)
1. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer.
Paolino D; Cosco D; Muzzalupo R; Trapasso E; Picci N; Fresta M
Int J Pharm; 2008 Apr; 353(1-2):233-42. PubMed ID: 18191509
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
[TBL] [Abstract][Full Text] [Related]
3. Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil.
Cosco D; Paolino D; Muzzalupo R; Celia C; Citraro R; Caponio D; Picci N; Fresta M
Biomed Microdevices; 2009 Oct; 11(5):1115-25. PubMed ID: 19507033
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
[TBL] [Abstract][Full Text] [Related]
5. A new crown ether as vesicular carrier for 5-fluoruracil: synthesis, characterization and drug delivery evaluation.
Muzzalupo R; Nicoletta FP; Trombino S; Cassano R; Iemma F; Picci N
Colloids Surf B Biointerfaces; 2007 Aug; 58(2):197-202. PubMed ID: 17434295
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo.
Wang M; Yuan Y; Gao Y; Ma HM; Xu HT; Zhang XN; Pan WS
Drug Dev Ind Pharm; 2012 Sep; 38(9):1134-41. PubMed ID: 22182601
[TBL] [Abstract][Full Text] [Related]
8. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles.
Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J
J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277
[TBL] [Abstract][Full Text] [Related]
9. Niosomes from alpha,omega-trioxyethylene-bis(sodium 2-dodecyloxy-propylenesulfonate): preparation and characterization.
Muzzalupo R; Tavano L; Trombino S; Cassano R; Picci N; La Mesa C
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):200-7. PubMed ID: 18378125
[TBL] [Abstract][Full Text] [Related]
10. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
[TBL] [Abstract][Full Text] [Related]
11. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
12. Preparation of curcuminoid niosomes for enhancement of skin permeation.
Rungphanichkul N; Nimmannit U; Muangsiri W; Rojsitthisak P
Pharmazie; 2011 Aug; 66(8):570-5. PubMed ID: 21901978
[TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Guinedi AS; Mortada ND; Mansour S; Hathout RM
Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
[TBL] [Abstract][Full Text] [Related]
14. Liposomes and niosomes as topical drug delivery systems.
Choi MJ; Maibach HI
Skin Pharmacol Physiol; 2005; 18(5):209-19. PubMed ID: 16015019
[TBL] [Abstract][Full Text] [Related]
15. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
Puri R; Jain S
Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
[TBL] [Abstract][Full Text] [Related]
16. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin.
Tavano L; Alfano P; Muzzalupo R; de Cindio B
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):333-9. PubMed ID: 21684725
[TBL] [Abstract][Full Text] [Related]
17. [Studies on the preparation of camptothecin niosomes].
Luan LB; Zhu JB; Yu WP; Wei KB
Yao Xue Xue Bao; 2002 Jan; 37(1):59-62. PubMed ID: 12579902
[TBL] [Abstract][Full Text] [Related]
18. AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil.
Gupta RR; Jain SK; Varshney M
Colloids Surf B Biointerfaces; 2005 Mar; 41(1):25-32. PubMed ID: 15698753
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of bolaform surfactant vesicles.
Muzzalupo R; Trombino S; Iemma F; Puoci F; La Mesa C; Picci N
Colloids Surf B Biointerfaces; 2005 Dec; 46(2):78-83. PubMed ID: 16257519
[TBL] [Abstract][Full Text] [Related]
20. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B.
Vyas SP; Singh RP; Jain S; Mishra V; Mahor S; Singh P; Gupta PN; Rawat A; Dubey P
Int J Pharm; 2005 May; 296(1-2):80-6. PubMed ID: 15885458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
